AUTOLUS THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.8 USD | -0.83% |
|
-9.94% | -25.47% |
Chart calendar Autolus Therapeutics plc
ae4ae6a94ff5504cb91fe006b79379.HdmBxFK-L42CJ2tk3f-aSBOcdvW5yNedcRiGdhdc0Ms.Wba5pRuGZtzqXQEHv6moPUDYN5bP8effNXWyOVBr6KIksdHpZula7M5NBA~c0921b45b182ab6086460487910574d8
Upcoming events on Autolus Therapeutics plc
Past events on Autolus Therapeutics plc
| 2024-03-14 08:30 am | Q4 2023 Earnings Call |
| 2024-03-14 07:00 am | Q4 2023 Earnings Release |
| 2023-12-11 09:00 pm | American Society of Hematology Meeting - Michael Merges |
| 2023-12-09 08:30 pm | American Society of Hematology Meeting - Dr. Claire Roddie |
| 2023-12-09 07:15 pm | American Society of Hematology Meeting - Dr. Lydia Lee |
| 2023-12-09 06:15 pm | American Society of Hematology Meeting - Dr. Claire Roddie |
| 2023-11-28 11:30 am | Piper Sandler Healthcare Conference - Fireside Chat |
| 2023-11-16 04:00 am | Jefferies London Healthcare Conference - Fireside Chat |
| 2023-11-09 11:40 am | Truist Securities Healthcare Conference - Panel |
| 2023-11-02 09:00 am | Q3 2023 Earnings Call |
| 2023-11-02 07:00 am | Q3 2023 Earnings Release |
| 2023-10-24 08:30 am | Business Update Call |
| 2023-10-10 | Cell & Gene Meeting on the Mesa Conference |
| 2023-08-03 08:30 am | Q2 2023 Earnings Call |
| 2023-08-03 07:01 am | Q2 2023 Earnings Release |
| 2023-06-30 06:00 am | Annual General Meeting |
| 2023-06-15 10:30 am | International Malignant Lymphoma Conference - Abstract No: 044 |
| 2023-06-10 11:00 am | European Hematology Association Hybrid Congress - Presentation ID: S262 |
| 2023-06-02 04:00 pm | American Society of Clinical Oncology Conference |
| 2023-06-02 02:00 pm | American Society of Clinical Oncology Conference - Abstract No. - #7000 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2,91 3,12 -6.68% | 1,72 1,52 12.66% | 2,33 7,20 -67.66% | 6,36 10,8 -41.26% | 1,70 1,70 -0.01% | 30,5 |
|
EBITDA Million USD | Released Forecast Spread | -137 -123 -12.02% | -161 -153 -4.84% | -154 -128 -20.1% | -154 -169 8.65% | 0,00 -180 - | -125 |
|
EBIT Million USD | Released Forecast Spread | -142 -141 -0.61% | -166 -164 -1.44% | -163 -154 -5.37% | -162 -170 4.67% | -180 -186 3.34% | -166 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -139 -130 -6.61% | -166 -160 -3.64% | -166 -158 -4.76% | -173 -177 2.01% | -208 -191 -9.06% | -188 |
|
Net income Million USD | Released Forecast Spread | -124 -116 -6.93% | -142 -137 -3.99% | -142 -134 -5.88% | -149 -153 2.8% | -208 -174 -20.06% | -174 |
|
EPS USD | Released Forecast Spread | -2,88 -2,70 -6.67% | -2,76 -2,66 -3.63% | -1,97 -1,89 -4.39% | -1,57 -1,63 3.54% | -1,20 -1,10 -8.65% | -0,79 |
| Announcement Date | 03/03/20 | 04/03/21 | 10/03/22 | 07/03/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,18 5,85 -96.93% | 0,17 0,17 -3.17% | 0,00 0,24 - | 2,37 0,14 1654.81% | 3,83 9,94 -61.53% | 1,29 0,35 265.88% | 0,00 0,10 - | 0,41 0,52 -22.02% | 0,00 0,26 - | 25,0 | 0,05 | 0,11 | 2,53 | 17,6 |
|
EBITDA Million USD | Released Forecast Spread | -47,2 | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -46,9 -35,9 -30.46% | -41,6 -44,4 6.19% | -46,5 -43,1 -7.94% | -43,5 -46,2 5.91% | -32,5 -37,7 13.87% | -43,1 -42,5 -1.31% | -47,9 -43,2 -10.75% | -47,8 -47,5 -0.75% | -40,9 -48,6 15.87% | -11,7 | -47,2 | -49,7 | -48,5 | -30,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -48,1 -41,0 -17.19% | -42,7 -44,5 4.12% | -49,5 -42,9 -15.43% | -48,9 -46,9 -4.27% | -32,1 -36,4 11.95% | -43,8 -47,1 7.08% | -49,0 -44,2 -10.91% | -50,8 -49,4 -2.86% | -64,8 -50,5 -28.43% | -27,1 | -54,0 | -56,9 | -55,3 | -30,8 |
|
Net income Million USD | Released Forecast Spread | -41,7 -34,0 -22.41% | -37,1 -40,2 7.9% | -42,1 -38,6 -9.04% | -42,8 -43,1 0.82% | -27,0 -30,9 12.75% | -39,8 -43,2 7.8% | -45,6 -40,4 -12.83% | -45,8 -44,2 -3.66% | -77,2 -45,3 -70.41% | -24,7 | -50,5 | -53,1 | -51,6 | -30,8 |
|
EPS USD | Released Forecast Spread | -0,51 -0,45 -13.74% | -0,41 -0,48 15.33% | -0,46 -0,33 -41.53% | -0,47 -0,47 0.17% | -0,23 -0,31 25.67% | -0,23 -0,27 16.15% | -0,26 -0,23 -14.47% | -0,26 -0,26 -1.3% | -0,45 -0,26 -72.73% | -0,15 | -0,22 | -0,23 | -0,23 | -0,20 |
| Announcement Date | 10/03/22 | 05/05/22 | 04/08/22 | 03/11/22 | 07/03/23 | 04/05/23 | 03/08/23 | 02/11/23 | 14/03/24 | - | - | - | - | - |
More events
Past sector events for Autolus Therapeutics plc
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AUTL Stock
- Calendar Autolus Therapeutics plc
